68 related articles for article (PubMed ID: 9671394)
1. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene.
Sekido Y; Ahmadian M; Wistuba II; Latif F; Bader S; Wei MH; Duh FM; Gazdar AF; Lerman MI; Minna JD
Oncogene; 1998 Jun; 16(24):3151-7. PubMed ID: 9671394
[TBL] [Abstract][Full Text] [Related]
2. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss.
Maitra A; Wistuba II; Washington C; Virmani AK; Ashfaq R; Milchgrub S; Gazdar AF; Minna JD
Am J Pathol; 2001 Jul; 159(1):119-30. PubMed ID: 11438460
[TBL] [Abstract][Full Text] [Related]
3. Deletions of DNA in cancer and their possible uses for therapy.
Varshavsky A; Lewis K; Chen SJ
Bioessays; 2023 Jul; 45(7):e2300051. PubMed ID: 37166062
[TBL] [Abstract][Full Text] [Related]
4. Correction to: Human artificial chromosome carrying 3p21.3‑p22.2 region suppresses hTERT transcription in oral cancer cells.
Ohira T; Yoshimura K; Kugoh H
Chromosome Res; 2023 Aug; 31(3):20. PubMed ID: 37589769
[No Abstract] [Full Text] [Related]
5. Tumor Suppressor Candidate 2 (TUSC2): Discovery, Functions, and Cancer Therapy.
Arrigo A; Regua AT; Najjar MK; Lo HW
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173921
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Fus1/Tusc2 and cellular Ca2
Uzhachenko R; Shimamoto A; Chirwa SS; Ivanov SV; Ivanova AV; Shanker A
Cancer Gene Ther; 2022 Oct; 29(10):1307-1320. PubMed ID: 35181743
[TBL] [Abstract][Full Text] [Related]
7. Type I Interferon Regulates a Coordinated Gene Network to Enhance Cytotoxic T Cell-Mediated Tumor Killing.
Fan JB; Miyauchi S; Xu HZ; Liu D; Kim LJY; Burkart C; Cheng H; Arimoto KI; Yan M; Zhou Y; Győrffy B; Knobeloch KP; Rich JN; Cang H; Fu XD; Zhang DE
Cancer Discov; 2020 Mar; 10(3):382-393. PubMed ID: 31974171
[TBL] [Abstract][Full Text] [Related]
8. MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells.
Rajabi H; Hata T; Li W; Long MD; Hu Q; Liu S; Raina D; Kui L; Yasumizu Y; Hong D; Samur M; Kufe D
Oncogene; 2019 Nov; 38(47):7266-7277. PubMed ID: 31435022
[TBL] [Abstract][Full Text] [Related]
9.
Kinney N; Varghese RT; Anandakrishnan R; Garner HRS
Cancer Inform; 2017; 16():1176935117746644. PubMed ID: 29276372
[TBL] [Abstract][Full Text] [Related]
10. Impact of Natural Compounds on DNA Methylation Levels of the Tumor Suppressor Gene RASSF1A in Cancer.
Dammann RH; Richter AM; Jiménez AP; Woods M; Küster M; Witharana C
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039788
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA).
Zhan L; Zhang B; Tan Y; Yang C; Huang C; Wu Q; Zhang Y; Chen X; Zhou M; Shu A
Medicine (Baltimore); 2017 Feb; 96(7):e6097. PubMed ID: 28207521
[TBL] [Abstract][Full Text] [Related]
12. Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma.
Doçi CL; Mikelis CM; Lionakis MS; Molinolo AA; Gutkind JS
Cancer Res; 2015 Jul; 75(14):2937-48. PubMed ID: 25952650
[TBL] [Abstract][Full Text] [Related]
13. Tumor-suppressive function of protein-tyrosine phosphatase non-receptor type 23 in testicular germ cell tumors is lost upon overexpression of miR142-3p microRNA.
Tanaka K; Kondo K; Kitajima K; Muraoka M; Nozawa A; Hara T
J Biol Chem; 2013 Aug; 288(33):23990-9. PubMed ID: 23843459
[TBL] [Abstract][Full Text] [Related]
14. RASSF Signalling and DNA Damage: Monitoring the Integrity of the Genome?
Scrace SF; O'Neill E
Mol Biol Int; 2012; 2012():141732. PubMed ID: 22577550
[TBL] [Abstract][Full Text] [Related]
15. A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.
Yee KS; Grochola L; Hamilton G; Grawenda A; Bond EE; Taubert H; Wurl P; Bond GL; O'Neill E
Cancer Res; 2012 May; 72(9):2206-17. PubMed ID: 22389451
[TBL] [Abstract][Full Text] [Related]
16. Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines.
da Costa Prando E; Cavalli LR; Rainho CA
Epigenetics; 2011 Dec; 6(12):1413-24. PubMed ID: 22139571
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor RASSF1A is a novel effector of small G protein Rap1A.
Verma SK; Ganesan TS; Kishore U; Parker PJ
Protein Cell; 2011 Mar; 2(3):237-49. PubMed ID: 21468893
[TBL] [Abstract][Full Text] [Related]
18. A precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancers.
Yu K; Ganesan K; Tan LK; Laban M; Wu J; Zhao XD; Li H; Leung CH; Zhu Y; Wei CL; Hooi SC; Miller L; Tan P
PLoS Genet; 2008 Jul; 4(7):e1000129. PubMed ID: 18636107
[TBL] [Abstract][Full Text] [Related]
19. The Ras-association domain family (RASSF) members and their role in human tumourigenesis.
van der Weyden L; Adams DJ
Biochim Biophys Acta; 2007 Sep; 1776(1):58-85. PubMed ID: 17692468
[TBL] [Abstract][Full Text] [Related]
20. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS
BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
